Maternal thyroid hormones and fetal brain development

Current Opinion in Endocrinology and Diabetes

Volumn 12, Issue 1, 2005, Pages 23-30

  Chan, Shiao Y ^a   Franklyn, Jayne A ^a   Kilby, Mark D ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Fetal brain; Iodothyronine deiodinase enzymes; Maternal hypothyroidism; Monocarboxylate transporter 8; T3 mediated development

Indexed keywords

HORMONE; THYROID HORMONE; THYROXINE DEIODINASE;

BRAIN DEVELOPMENT; CELL MEMBRANE TRANSPORT; ENZYME ACTIVITY; FETUS DEVELOPMENT; GENE EXPRESSION; HORMONE ACTION; HUMAN; HYPOTHYROIDISM; MATERNAL DISEASE; REVIEW; SCREENING; SYNAPTOGENESIS; THYROID FUNCTION TEST; THYROID HORMONE METABOLISM; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; X LINKED MENTAL RETARDATION;

EID: 14944339012     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.med.0000151392.73904.69     Document Type: Review

References (75)

1. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341:549-555.
2. Pop VJ, Brouwers EP, Vader HL, et al. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf) 2003; 59:282-288. This is a sizable and well-conducted clinical study correlating maternal T4 levels to infant Bayley scores.
3. Pop VJ, Kuijpens JL, van Baar AL, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 1999; 50:149-155.
4. Klein KZ, Haddow JE, Faix JD, et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) 1991; 35:41-46.
5. Sullivan M: American Thyroid Association Statement: ID Subclinical Hypothyroidism Before Conception. Ob Gyn News 1 May 2004; Sect. 1-4. http:// www2.eObGynNews.com This news article summarizes the views presented at the most recent joint multidisciplinary meeting on screening for subclinical maternal hypothyroidism.
6. Kibirige MS, Hutchison S, Owen CJ, et al. Prevalence of maternal dietary iodine insufficiency in the north east of England: implications for the fetus. Arch Dis Child Fetal Neonatal Ed 2004; 89:F436-F439.
7. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291:228-238. This is a meta-analysis of the latest findings on subclinical hypothyroidism and contains the opinions of experts in this field of endocrinology.
8. Thorpe-Beeston JG, Nicolaides KH, Felton CV, et al. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 1991; 324:532-536.
9. Fisher DA: Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Clin Obstet Gynecol 1997; 40:16-31.
10. Shepard TH: Onset of function in the human fetal thyroid: biochemical and radioautographic studies from organ culture. J Clin Endocrinol Metab 1967; 27:945-958.
11. Fisher DA, Dussault JH, Sack J, et al. Ontogenesis of hypothalamic-pituitary-thyroid function and metabolism in man, sheep, and rat. Recent Prog Horm Res 1976; 33:59-116.
12. Brent GA: Maternal thyroid function: interpretation of thyroid function tests in pregnancy. Clin Obstet Gynecol 1997; 40:3-15.
13. de Escobar GM, Obregon MJ, del Rey FE: Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 2004; 18:225-248. This is a more detailed review of our latest understanding on maternal thyroid hormones and fetal brain development.
14. Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004; 351:241-249. This would be of interest to clinicians who treat hypothyroid women of reproductive age.
15. Kempers MJ, van Tijn DA, van Trotsenburg AS, et al. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab 2003; 88:5851-5857.
16. Santini F, Chiovato L, Ghirri P, et al. Serum iodothyronines in the human fetus and the newborn: evidence for an important role of placenta in fetal thyroid hormone homeostasis. J Clin Endocrinol Metab 1999; 84:493-498.
17. Chan S, Kachilele S, Hobbs E, et al. Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab 2003; 88:4488-4495.
18. Koopdonk-Kool JM, de Vijlder JJ, Veenboer GJ, et al. Type II and type III deiodinase activity in human placenta as a function of gestational age. J Clin Endocrinol Metab 1996; 81:2154-2158.
19. Vulsma T, Gons MH, de Vijlder JJ: Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organisation defect or thyroid agenesis. N Engl J Med 1989; 321:13-16.
20. Contempre B, Jauniaux E, Calvo R, et al. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab 1993; 77:1719-1722.
21. Costa A, Arisio R, Benedetto C, et al. Thyroid hormones in tissues from human embryos and fetuses. J Endocrinol Invest 1991; 14:559-568.
22. Calvo RM, Jauniaux E, Gulbis B, et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 2002; 87:1768-1777.
23. Karmarkar MG, Prabarkaran D, Godbole MM: 5′-Monodeiodinase activity in developing human cerebral cortex. Am J Clin Nutr 1993; 57(suppl):291S-294S.
24. Sinha AP, Godbole M, Chattopadhyay N, et al. Thyroid hormone and brain maturation. Recent Res Dev Neurobiol 1997:1-14.
25. Santini F, Hurd RE, Lee B, et al. Thyromimetic effects of 3,5,3′-triiodothyronine sulfate in hypothyroid rats. Endocrinology 1993; 133:105-110.
26. Richard K, Hume R, Kaptein E, et al. Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab 2001; 86:2734-2742.
27. Visser TJ: Role of sulfate in thyroid hormone sulfation. Eur J Endocrinol 1996; 134:12-14.
28. Hume R, Simpson J, Delahunty C, et al. Human fetal and cord serum thyroid hormones: developmental trends and interrelationships. J Clin Endocrinol Metab 2004; 89:4097-4103. This would be of interest to those investigating thyroid hormone effects during human fetal development.
29. Kilby MD, Verhaeg J, Gittoes N, et al. Circulating thyroid hormone concentrations and placental thyroid hormone receptor expression in normal human pregnancy and pregnancy complicated by intrauterine growth restriction (IUGR). J Clin Endocrinol Metab 1998; 83:2964-2971.
30. Van Wassenaer AG, Kok JH, Briet JM, et al. Thyroid function in preterm newborns: is T4 treatment required in infants <27 weeks' gestational age? Exp Clin Endocrinol Diabetes 1997; 105(suppl 4):12-18.
31. Kester MH, Martinez de Mena R, Obregon MJ, et al. Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab 2004; 89:3117-3128. This is the most detailed study of deiodinase ontogeny in human fetal brains to date.
32. Friesema EC, Ganguly S, Abdalla A, et al. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 2003; 278:40128-40135. This paper details a comprehensive study of the function of the rat MCT8 as a thyroid hormone transporter.
33. Dumitrescu AM, Liao XH, Best TB, et al. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004; 74:168-175.
34. Friesema E, Grueters A, Biebermann H, et al. Severe X-linked psychomotor retardation caused by mutations in a thyroid hormone transporter. Lancet 2004. (In press) This paper highlights the importance of MCT8 specifically in human brain development and details the particular mutations discovered thus far.
35. Chan SY, McCabe CJ, Boelaert K: et al. The expression of monocarboxylate transporter 8, as a specific thyroid hormone transporter in human fetal brain and placenta: the effects of intrauterine growth restriction (IUGR). In: 23rd Joint Meeting of the British Endocrine Societies. Brighton: Endocrine Abstract; 2004:OC9.
36. Sugiyama D, Kusuhara H, Taniguchi H, et al. Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine. J Biol Chem 2003; 278:43489-43495.
37. Chan S, Kachilele S, McCabe CJ, et al. Early expression of thyroid hormone deiodinases and receptors in human fetal cerebral cortex. Brain Res Dev Brain Res 2002; 138:109-116.
38. Kohrle J: Thyroid hormone metabolism and action in the brain and pituitary. Acta Med Austriaca 2000; 27:1-7.
39. Crantz FR, Silva JE, Larsen PR: An analysis of the sources and quantity of 3,5,3′-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology 1982; 110:367-375.
40. Morreale de Escobar G, Calvo R, Obregon MJ, et al. Homeostasis of brain T3 in rat fetuses and their mothers: effects of thyroid status and iodine deficiency. Acta Med Austriaca 1992; 19(suppl 1):110-116.
41. Chan S, McCabe CJ, Visser TJ, et al. Thyroid hormone responsiveness in N-Tera-2 cells. J Endocrinol 2003; 178:159-167.
42. Esfandiari A, Courtin F, Lennon AM, et al. Induction of type III deiodinase activity in astroglial cells by thyroid hormones. Endocrinology 1992; 131:1682-1688.
43. Pruvost V, Valentin S, Cheynel I, et al. 5′-Deiodinase activity in cultured glial and fibroblastic cells from the cerebella of newborn rats. Horm Metab Res 1999; 31:591-596.
44. Ng L, Goodyear RJ, Woods CA, et al. Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proc Natl Acad Sci U S A 2004; 101:3474-3479.
45. Gallon V, Wood E, St. Germain D: Type 2 deiodinase (D2) is not essential for all thyroid hormone-dependent developmental processes in the mouse central nervous system (CNS). In: 75th Annual Meeting of the American Thyroid Association, 2003 September 2003, Florida, USA: Thyroid. 2003:907.
46. Campos-Barros A, Hoell T, Musa A, et al. Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system. J Clin Endocrinol Metab 1996; 81:2179-2185.
47. Quo TW, Zhang FC, Yang MS, et al. Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China. J Med Genet 2004; 41:585-590.
48. Farwell AP, Leonard JL: Dissociation of actin polymerization and enzyme inactivation in the hormonal regulation of type II iodothyronine 5′-deiodinase activity in astrocytes, Endocrinology 1992; 131:721-728.
49. Bernal J, Pekonen F: Ontogenesis of the nuclear 3,5,3′- triiodothyronine receptor in the human fetal brain. Endocrinology 1984; 114:677-679.
50. Kilby MD, Gittoes N, McCabe C, et al. Expression of thyroid receptor isoforms in the human fetal central nervous system and the effects of intrauterine growth restriction. Clin Endocrinol (Oxf) 2000; 53:469-477.
51. Gothe S, Wang Z, Ng L, et al. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 1999; 13:1329-1341.
52. Sachs LM, Jones PL, Havis E, et al. Nuclear receptor corepressor recruitment by unliganded thyroid hormone receptor in gene repression during Xenopus laevis development. Mol Cell Biol 2002; 22:8527-8538.
53. Buchholz DR, Hsia SC, Fu L, et al. A dominant-negative thyroid hormone receptor blocks amphibian metamorphosis by retaining corepressors at target genes. Mol Cell Biol 2003; 23:6750-6758.
54. Makowski A, Brzostek S, Cohen RN, et al. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor. Mol Endocrinol 2003; 17:273-286.
55. Refetoff S, Weiss RE, Usala SJ: The syndromes of resistance to thyroid hormone. Endocr Rev 1993; 14:348-399.
56. Brucker-Davis F, Skarulis MC, Grace MB, et al. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann Intern Med 1995; 123:572-583.
57. Tinnikov A, Nordstrom K, Thoren P, et al. Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1. EMBO J 2002; 21:5079-5087.
58. Anderson GW: Thyroid hormones and the brain. Front Neuroendocrinol 2001; 22:1-17.
59. O'Shea PJ, Williams GR: Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. J Endocrinol 2002; 175:553-570.
60. Morte B, Manzano J, Scanlan TS, et al. Aberrant maturation of astrocytes in thyroid hormone receptor alpha 1 knockout mice reveals an interplay between thyroid hormone receptor isoforms. Endocrinology 2004; 145:1386-1391.
61. Tosic M, Rakic S, Matthieu JM, et al. Identification of Golli and myelin basic proteins in human brain during early development. Glia 2002; 37:219-228.
62. Denver RJ: The molecular basis of thyroid hormone-dependent central nervous system remodeling during amphibian metamorphosis. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1998; 119:219-228.
63. Anderson GW, Schoonover CM, Jones SA: Control of thyroid hormone action in the developing rat brain. Thyroid 2003; 13:1039-1056.
64. Bernal J, Guadano-Ferraz A, Morte B: Perspectives in the study of thyroid hormone action on brain development and function. Thyroid 2003; 13: 1005-1012. The previous two reviews explains in more detail our current understanding the of thyroid hormones mediate their effects during brain development.
65. Liu JL, Tan YB, Zhuang ZJ, et al. Morphologic studies of therapeutically aborted fetus thyroid in an endemic goiter region of Guizhou Province. Chin Med J (Engl) 1982; 95:347-354.
66. Hosoda R, Nakayama K, Kato-Negishi M, et al. Thyroid hormone enhances the formation of synapses between cultured neurons of rat cerebral cortex. Cell Mol Neurobiol 2003; 23:895-906.
67. Sui L, Gilbert ME: Pre- and postnatal propylthiouracil-induced hypothyroidism impairs synaptic transmission and plasticity in area CA1 of the neonatal rat hippocampus. Endocrinology 2003; 144:4195-4203.
68. Gilbert ME, Paczkowski C: Propylthiouracil (PTU)-induced hypothyroidism in the developing rat impairs synaptic transmission and plasticity in the dentate gyrus of the adult hippocampus. Brain Res Dev Brain Res 2003; 145:19-29. The previous two papers describes the long-term impact of hypothyroidism during development on synaptic function in adulthood in rats.
69. Dowling AL, Zoeller RT: Thyroid hormone of maternal origin regulates the expression of RC3/neurogranin mRNA in the fetal rat brain. Brain Res Mol Brain Res 2000; 82:126-132.
70. Dowling AL, Martz GU, Leonard JL, et al. Acute changes in maternal thyroid hormone induce rapid and transient changes in gene expression in fetal rat brain. J Neurosci 2000; 20:2255-2265.
71. Lavado-Autric R, Auso E, Garcia-Velasco JV, et al. Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest 2003; 111:1073-1082. One of the first studies to investigate the impact of subclinical maternal hypothyroidism on fetal brain development in rats.
72. Oppenheimer JH, Schwartz HL: Molecular basis of thyroid hormone-dependent brain development. Endocr Rev 1997; 18:462-475.
73. Cao XY, Jiang XM, Dou ZH, et al. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. N Engl J Med 1994; 331:1739-1744.
74. Mirabella G, Feig D, Astzalos E, et al. The effect of abnormal intrauterine thyroid hormone economies on infant cognitive abilities. J Pediatr Endocrinol Metab 2000; 13:191-194.
75. Song SI, Daneman D, Rovet J: The influence of etiology and treatment factors on intellectual outcome in congenital hypothyroidism. J Dev Behav Pediatr 2001; 22:376-384.